More Dividends, Less Drama: 3 Of My Favorite Dividend Stocks (5-7% Yield)
Amid rising risks, I favor high-yield stocks with strong business models. Check out the stock picks that offer stability, ...
1 Reliable Dividend Stock You Can Buy Now and Hold at Least a Decade
Investor enthusiasm hit a fever pitch following the 2024 election, but took a punch to the gut recently. Market indexes have ...
Pfizer (NYSE:PFE) Receives “Buy” Rating from Guggenheim
Pfizer (NYSE:PFE – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Guggenheim in a research ...
Investing Snacks8h
Pfizer’s Hidden Value: A Biotech Giant on Sale
Pfizer Inc. stands out as an undervalued biotech stock with strong dividend potential and ambitious oncology expansion. The company boasts a forward P/E of 8.82, making it significantly cheaper than ...
Pfizer (NYSE:PFE) To Divest Entire 7 Percent Stake In Haleon Through Share Offering
Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment ...
Pfizer Inc. (PFE): The Most Undervalued Biotech Stock to Invest In
We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...
Fierce Pharma23h
Pfizer pockets roughly £2.5B as it shaves off final stake in consumer health spinoff Haleon
With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...
Pfizer sells entire Haleon stake for $3.24 billion
Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors ...
Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant
Pfizer has finalized the sale of its entire holding in Haleon , generating approximately 2.5 billion ($3.24 billion), Reuters ...
Pfizer exits Haleon stake after $3.2B share sale
Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.
Pfizer Wraps Up Haleon Exit With $3.3 Billion Stake Sale
Pfizer Inc. raised about £2.55 billion ($3.3 billion) through the sale of its remaining 7.3% stake in Haleon Plc, culminating ...
Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion
Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...